aid: abkbiomedical
name: ABK Biomedical
description: ABK Biomedical Inc. is a Halifax, Nova Scotia medical device company founded in 2012 as a spin-out
  of Dalhousie University, developing and manufacturing imageable embolic microspheres for interventional oncology.
  Its lead product, Eye90 microspheres, is a yttrium-90 radioembolization device built on a proprietary imageable
  glass composition that is directly visible under fluoroscopy, X-ray and CT during and after the procedure, and
  it was granted FDA Breakthrough Device Designation for unresectable hepatocellular carcinoma and studied in the
  ROUTE90 pivotal trial. Its Easi-Vue embolic microspheres received FDA 510(k) clearance for embolization of
  hypervascular tumors and arteriovenous malformations. Devices are produced in the company's own cleanroom
  manufacturing facility in Halifax, with a second office in Ladera Ranch, California. ABK Biomedical is a
  regulated medical device manufacturer rather than a software vendor, and as of this profile it publishes no
  developer program, API documentation, SDK, or machine-readable API contract of any kind.
url: https://raw.githubusercontent.com/api-evangelist/abkbiomedical/refs/heads/main/apis.yml
x-type: company
x-source: harvest:secondary-market
specificationVersion: '0.20'
created: '2026-09-06'
modified: '2026-09-06'
tags:
- Medical Devices
- Interventional Oncology
- Radioembolization
- Medical Imaging
- Oncology
- Healthcare
- Manufacturing
- Canada
- Company
apis: []
maintainers:
- FN: Kin Lane
  email: kin@apievangelist.com
- FN: APIs.json
  email: info@apis.io
common:
- type: Website
  url: https://abkbiomedical.com/
- type: LinkedIn
  url: https://ca.linkedin.com/company/abk-biomedical-inc-
- type: SecondaryMarket
  url: https://equityzen.com/company/abkbiomedical
- type: DomainSecurity
  url: security/abkbiomedical-domain-security.yml
x-tier: profiled
x-tier-reason: 'enrichment pass 2026-09-06: full STEP 0b contract discovery run against every known host,
  no public API surface found'
x-enrichment:
  date: '2026-09-06'
  status: minimal
  artifacts_added: 2
  pass: local-v3
x-coverage:
  state: none
  reason: not-a-software-company
  detail: 'ABK Biomedical manufactures implantable radioembolization and embolic microspheres (Eye90, Easi-Vue)
    in its own Halifax cleanroom rather than software: no api., developer., dev., portal., app. or data. host
    exists in DNS, there is no GitHub organization and no package under this name on npm or PyPI, and
    abkbiomedical.com is a SiteGround-hosted marketing site whose every path — /robots.txt included — answers
    HTTP 202 with an sg-captcha interstitial rather than any document.'
  evidence:
  - url: https://abkbiomedical.com/.well-known/api-catalog
    status: 202
  - url: https://abkbiomedical.com/openapi.json
    status: 202
  - url: https://api.github.com/orgs/abkbiomedical
    status: 404
  - url: https://pypi.org/pypi/abkbiomedical/json
    status: 404
  - url: https://registry.npmjs.org/-/v1/search?text=abkbiomedical
    status: 200
  - url: https://equityzen.com/company/abkbiomedical
    status: 200
  checked: '2026-09-06'